Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tumorigenic cell lines altered by genetic engineering and their use for the testing of antitumor drugs

Tumorigenic cell lines altered by genetic engineering and their use for the testing of antitumor drugs

US Patent 5837462 · Granted Nov 17, 1998

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Composition comprising EPA and DHA for an enhanced efficacy of anticancer agents2022
Hydroxyalkyl starch for the treatment of hematological neoplasms2019
Detection of starch levels in biological matrices2019
Orthosis for treating rhizarthrosis2017
Fused bicyclic imidazoles2016
Lumbar support belt2016
Sulfonylpyrroles2015
Fused pyrimidines2015
N-sulphonylpyrroles and their use as histone deacetylase inhibitors2014
Fused bicyclic pyrimidines2013
Fused bicyclic imidazoles2013
N-substituted tetrahydroisoquinoline/isoindoline hydroxamic acid compounds2013